0001140361-23-043270.txt : 20230907 0001140361-23-043270.hdr.sgml : 20230907 20230907213016 ACCESSION NUMBER: 0001140361-23-043270 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230905 FILED AS OF DATE: 20230907 DATE AS OF CHANGE: 20230907 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kumar Rakhi CENTRAL INDEX KEY: 0001856296 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40782 FILM NUMBER: 231243588 MAIL ADDRESS: STREET 1: C/O NEUROPACE INC STREET 2: 455 N BERNARDO AVENUE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Roivant Sciences Ltd. CENTRAL INDEX KEY: 0001635088 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981173944 STATE OF INCORPORATION: D0 FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: CLARENDON HOUSE, 2 CHURCH STREET CITY: HAMILTON HM11 STATE: D0 ZIP: HM11 BUSINESS PHONE: 441-295-5950 MAIL ADDRESS: STREET 1: CLARENDON HOUSE STREET 2: 2 CHURCH STREET CITY: HAMILTON STATE: D0 ZIP: HM11 4 1 form4.xml X0508 4 2023-09-05 0001635088 Roivant Sciences Ltd. ROIV 0001856296 Kumar Rakhi C/O ROIVANT SCIENCES LTD. 7TH FLOOR, 50 BROADWAY LONDON X0 SW1H 0DB UNITED KINGDOM true Chief Accounting Officer false Common Shares 2023-09-05 4 M 0 1724 6.48 A 199674 D Common Shares 2023-09-05 4 S 0 1724 12 D 197950 D Stock Option (Right to Buy) 6.48 2023-09-05 4 M 0 1724 0 D 2027-05-21 Common Shares 1724 99350 D The price reported in column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. These sales were effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2023. Award of stock options to purchase Common Shares with a vesting commencement date of May 20, 2017. The award of stock options is fully vested. By: /s/ Jo Chen, as Attorney-in-Fact for Rakhi Kumar 2023-09-07